New program combines drug checking and HIV prevention to save lives
NCT ID NCT05977881
First seen Jan 12, 2026 · Last updated Jun 14, 2026 · Updated 25 times
Summary
This study tested a program that offers drug-checking services and HIV prevention medication (PrEP) to people who use drugs in Baltimore. The goal was to reduce both overdose risk and new HIV infections. About 493 participants joined, and researchers tracked whether they started or stayed on PrEP and whether their HIV risk behaviors changed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins School of Public Health
Baltimore, Maryland, 21205, United States
Conditions
Explore the condition pages connected to this study.